首页 > 最新文献

European Journal of Cardio-Thoracic Surgery最新文献

英文 中文
2024 EACTS Guidelines on perioperative medication in adult cardiac surgery. 2024 EACTS 成人心脏手术围手术期用药指南。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezae355
Anders Jeppsson, Bianca Rocca, Emma C Hansson, Tomas Gudbjartsson, Stefan James, Juan Carlos Kaski, Ulf Landmesser, Giovanni Landoni, Pedro Magro, Emily Pan, Hanne Berg Ravn, Sigrid Sandner, Elena Sandoval, Miguel Sousa Uva, Milan Milojevic
{"title":"2024 EACTS Guidelines on perioperative medication in adult cardiac surgery.","authors":"Anders Jeppsson, Bianca Rocca, Emma C Hansson, Tomas Gudbjartsson, Stefan James, Juan Carlos Kaski, Ulf Landmesser, Giovanni Landoni, Pedro Magro, Emily Pan, Hanne Berg Ravn, Sigrid Sandner, Elena Sandoval, Miguel Sousa Uva, Milan Milojevic","doi":"10.1093/ejcts/ezae355","DOIUrl":"10.1093/ejcts/ezae355","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142389046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Rajakumar. 回复Rajakumar。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezaf002
Tim Dong, Shubhra Sinha, Gianni D Angelini
{"title":"Reply to Rajakumar.","authors":"Tim Dong, Shubhra Sinha, Gianni D Angelini","doi":"10.1093/ejcts/ezaf002","DOIUrl":"10.1093/ejcts/ezaf002","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143002597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery for blood culture-negative infective endocarditis: outcomes and the role of molecular biological imaging as diagnostic approach†. 血培养阴性感染性心内膜炎的手术治疗:结果和分子生物学成像作为诊断方法的作用。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezae453
Herko Grubitzsch, Johannes Erik Puritz, Dustin Greve, Hector Rodriguez Cetina Biefer, Dinah von Schöning, Judith Kikhney, Annette Moter, Stefanie-Teodora Sima, Matthias Schneider-Reigbert, Miriam Songa Stegemann, Frieder Pfäfflin, Volkmar Falk

Objectives: The study aimed to analyse outcomes of surgery for blood culture-negative infective endocarditis (BCNIE) and to evaluate the role of molecular biological imaging.

Methods: Patients undergoing surgery for native or prosthetic valve endocarditis from 2013 to 2022 were analysed regarding blood culture-positive infective endocarditis (BCPIE) and BCNIE. For laboratory diagnostics in BCNIE, excised valves or prostheses underwent conventional microbiological culture and fluorescence in situ hybridization combined with 16S rRNA-gene polymerase chain reaction and sequencing (FISHseq).

Results: Of 521 patients overall, we identified 473 patients (342 males, mean age 63 ± 14.4 years) with preoperative blood cultures: 396 with BCPIE (83.7%) and 77 with BCNIE (16.3%). Preoperative characteristics and operative procedures were comparable between groups and the calculated perioperative risk (EuroSCORE II) was identical (BCNIE: 12.2 ± 8.8%, BCPIE: 12.9 ± 11.9%, P = 0.788). At surgery, signs of infective endocarditis were present in 71%, missing in 18% and inconclusive in 10% of patients with BCNIE. While valve cultures alone identified pathogens in 32% of BCNIE patients, the combination with FISHseq confirmed the infective aetiology in 98% and identified causative pathogens in 52%. Overall, early mortality was similar in BCNIE (16.9%) and BCPIE (18.2%, P = 0.620), but increased in 37 BCNIE patients without pathogen identification compared to 40 patients with pathogen identification (27.0% vs 7.5%, P = 0.032).

Conclusions: Integrating FISHseq as molecular biological imaging technique into valve analysis algorithms in patients undergoing surgery for BCNIE increases diagnostic gain and potentially improves outcome.

目的:分析血培养阴性感染性心内膜炎(BCNIE)的手术治疗效果,并评价分子生物学成像的作用。方法:对2013 - 2022年接受先天性或人工瓣膜心内膜炎手术的患者进行血培养阳性感染性心内膜炎(BCPIE)和BCNIE的分析。对于BCNIE的实验室诊断,切除的瓣膜或假体进行常规微生物培养和荧光原位杂交结合16S rrna基因聚合酶链反应和测序(FISHseq)。结果:在521例患者中,我们确定了473例患者(342例男性,平均年龄63±14.4岁)进行术前血培养:396例为BCPIE(83.7%), 77例为BCNIE(16.3%)。两组间术前特征和手术方式具有可比性,计算围手术期风险(EuroSCORE II)相同(BCNIE: 12.2±8.8%,BCPIE: 12.9±11.9%,p = 0.788)。手术时,71%的患者存在感染性心内膜炎征象,18%的患者不存在,10%的BCNIE患者不确定。单独瓣膜培养在32%的BCNIE患者中鉴定出病原体,联合FISHseq确认了98%的感染病因,鉴定了52%的致病病原体。总体而言,BCNIE(16.9%)和BCPIE (18.2%, p = 0.620)的早期死亡率相似,但未鉴定病原体的37例BCNIE患者的早期死亡率高于40例鉴定病原体的患者(27.0%对7.5%,p = 0.032)。结论:将FISHseq作为分子生物学成像技术整合到BCNIE手术患者的瓣膜分析算法中可以增加诊断收益,并可能改善预后。
{"title":"Surgery for blood culture-negative infective endocarditis: outcomes and the role of molecular biological imaging as diagnostic approach†.","authors":"Herko Grubitzsch, Johannes Erik Puritz, Dustin Greve, Hector Rodriguez Cetina Biefer, Dinah von Schöning, Judith Kikhney, Annette Moter, Stefanie-Teodora Sima, Matthias Schneider-Reigbert, Miriam Songa Stegemann, Frieder Pfäfflin, Volkmar Falk","doi":"10.1093/ejcts/ezae453","DOIUrl":"10.1093/ejcts/ezae453","url":null,"abstract":"<p><strong>Objectives: </strong>The study aimed to analyse outcomes of surgery for blood culture-negative infective endocarditis (BCNIE) and to evaluate the role of molecular biological imaging.</p><p><strong>Methods: </strong>Patients undergoing surgery for native or prosthetic valve endocarditis from 2013 to 2022 were analysed regarding blood culture-positive infective endocarditis (BCPIE) and BCNIE. For laboratory diagnostics in BCNIE, excised valves or prostheses underwent conventional microbiological culture and fluorescence in situ hybridization combined with 16S rRNA-gene polymerase chain reaction and sequencing (FISHseq).</p><p><strong>Results: </strong>Of 521 patients overall, we identified 473 patients (342 males, mean age 63 ± 14.4 years) with preoperative blood cultures: 396 with BCPIE (83.7%) and 77 with BCNIE (16.3%). Preoperative characteristics and operative procedures were comparable between groups and the calculated perioperative risk (EuroSCORE II) was identical (BCNIE: 12.2 ± 8.8%, BCPIE: 12.9 ± 11.9%, P = 0.788). At surgery, signs of infective endocarditis were present in 71%, missing in 18% and inconclusive in 10% of patients with BCNIE. While valve cultures alone identified pathogens in 32% of BCNIE patients, the combination with FISHseq confirmed the infective aetiology in 98% and identified causative pathogens in 52%. Overall, early mortality was similar in BCNIE (16.9%) and BCPIE (18.2%, P = 0.620), but increased in 37 BCNIE patients without pathogen identification compared to 40 patients with pathogen identification (27.0% vs 7.5%, P = 0.032).</p><p><strong>Conclusions: </strong>Integrating FISHseq as molecular biological imaging technique into valve analysis algorithms in patients undergoing surgery for BCNIE increases diagnostic gain and potentially improves outcome.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142834828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seven-year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicentre analysis. 1100 多名患者使用带支架的牛心包生物人工瓣膜进行主动脉瓣置换手术后的 7 年疗效:前瞻性多中心分析。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezae414
Joseph F Sabik, Vivek Rao, Francois Dagenais, Michael G Moront, Michael J Reardon, Himanshu J Patel, Jae K Oh, Shinichi Fukuhara, Louis Labrousse, Ralf Günzinger, Kamran Baig, Saki Ito, Tianhua Wu, Robert J M Klautz

Objectives: Safety, efficacy and durability are important considerations when selecting a bioprosthesis for aortic valve replacement (AVR). This study assessed 7-year clinical outcomes and haemodynamic performance of the Avalus bioprosthesis.

Methods: Patients indicated for surgical AVR were enrolled in this prospective, nonrandomized trial, conducted across 39 sites globally. The primary end-point of this analysis was freedom from surgical explant or percutaneous valve-in-valve reintervention due to structural valve deterioration (SVD) at 7 years of follow-up, determined using Kaplan-Meier (KM) analysis. We also evaluated a composite end-point of SVD and/or severe haemodynamic dysfunction requiring reintervention. Survival, valve-related safety events and haemodynamic performance were assessed. Deaths and safety events were adjudicated by an independent clinical events committee.

Results: A total of 1132 patients underwent surgical AVR. Mean age was 70 years; 854 patients (75%) were men. The mean STS risk of mortality was 2.0 ± 1.4%, and 659 patients (58%) had a New York Heart Association classification of I/II. One or more concomitant procedures were performed in 577 patients (51%). At 7 years, the Kaplan-Meier rate of freedom from SVD/severe haemodynamic dysfunction requiring reintervention was 1.2% (0.5-2.5%) with no cases adjudicated as SVD. The survival rate was 82.6% (79.5-85.0%). The KM event rate was 5.7% (4.3-7.7%) for reintervention, 6.3% (4.9-8.3%) for endocarditis and 0.4% (0.1-1.1%) for valve thrombosis. Mean aortic gradient, dimensionless velocity index and effective orifice area were 13.8 ± 5.9 mmHg, 0.42 ± 0.09 and 1.99 ± 0.53 cm2, respectively.

Conclusions: This analysis demonstrated excellent durability of the Avalus valve with good clinical outcomes and stable haemodynamic performance through 7 years of follow-up.

目的:在选择主动脉瓣置换术(AVR)的生物假体时,安全性、有效性和耐用性是重要的考虑因素。本研究评估了 Avalus 生物假体的 7 年临床疗效和血流动力学性能:这项前瞻性、非随机试验在全球 39 个地点进行,登记了有手术 AVR 适应症的患者。这项分析的主要终点是随访 7 年后是否因结构性瓣膜退化(SVD)而进行手术切除或经皮瓣膜置入再介入治疗,采用 Kaplan-Meier (KM) 分析法确定。我们还评估了SVD或严重血流动力学功能障碍(SHD)需要重新介入治疗的复合终点。我们对生存率、瓣膜相关安全事件和血流动力学表现进行了评估。死亡和安全事件由独立的临床事件委员会裁定:共有 1132 名患者接受了手术 AVR。平均年龄为 70 岁;854 名患者(75%)为男性。平均 STS 死亡风险为 2.0 ± 1.4%,659 名患者(58%)的 NYHA 分级为 I/II。577名患者(51%)同时进行了一种或多种手术。7年后,无SVD/SHD需要再次干预的Kaplan-Meier率为1.2%(0.5-2.5%),无病例被判定为SVD。存活率为 82.6%(79.5%-85.0%)。KM事件发生率为:再介入5.7%(4.3-7.7%),心内膜炎6.3%(4.9-8.3%),瓣膜血栓0.4%(0.1-1.1%)。平均主动脉瓣梯度、无量纲速度指数和有效瓣口面积分别为 13.8 ± 5.9 mmHg、0.42 ± 0.09 和 1.99 ± 0.53 cm2:这项分析表明Avalus瓣膜具有良好的耐久性,在7年的随访中取得了良好的临床效果和稳定的血流动力学表现。注册:www.clinicaltrials.gov ID:NCT02088554.
{"title":"Seven-year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicentre analysis.","authors":"Joseph F Sabik, Vivek Rao, Francois Dagenais, Michael G Moront, Michael J Reardon, Himanshu J Patel, Jae K Oh, Shinichi Fukuhara, Louis Labrousse, Ralf Günzinger, Kamran Baig, Saki Ito, Tianhua Wu, Robert J M Klautz","doi":"10.1093/ejcts/ezae414","DOIUrl":"10.1093/ejcts/ezae414","url":null,"abstract":"<p><strong>Objectives: </strong>Safety, efficacy and durability are important considerations when selecting a bioprosthesis for aortic valve replacement (AVR). This study assessed 7-year clinical outcomes and haemodynamic performance of the Avalus bioprosthesis.</p><p><strong>Methods: </strong>Patients indicated for surgical AVR were enrolled in this prospective, nonrandomized trial, conducted across 39 sites globally. The primary end-point of this analysis was freedom from surgical explant or percutaneous valve-in-valve reintervention due to structural valve deterioration (SVD) at 7 years of follow-up, determined using Kaplan-Meier (KM) analysis. We also evaluated a composite end-point of SVD and/or severe haemodynamic dysfunction requiring reintervention. Survival, valve-related safety events and haemodynamic performance were assessed. Deaths and safety events were adjudicated by an independent clinical events committee.</p><p><strong>Results: </strong>A total of 1132 patients underwent surgical AVR. Mean age was 70 years; 854 patients (75%) were men. The mean STS risk of mortality was 2.0 ± 1.4%, and 659 patients (58%) had a New York Heart Association classification of I/II. One or more concomitant procedures were performed in 577 patients (51%). At 7 years, the Kaplan-Meier rate of freedom from SVD/severe haemodynamic dysfunction requiring reintervention was 1.2% (0.5-2.5%) with no cases adjudicated as SVD. The survival rate was 82.6% (79.5-85.0%). The KM event rate was 5.7% (4.3-7.7%) for reintervention, 6.3% (4.9-8.3%) for endocarditis and 0.4% (0.1-1.1%) for valve thrombosis. Mean aortic gradient, dimensionless velocity index and effective orifice area were 13.8 ± 5.9 mmHg, 0.42 ± 0.09 and 1.99 ± 0.53 cm2, respectively.</p><p><strong>Conclusions: </strong>This analysis demonstrated excellent durability of the Avalus valve with good clinical outcomes and stable haemodynamic performance through 7 years of follow-up.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing machine learning based mortality predictions in cardiac surgery: unlocking the full potential of ML-based risk scores. 增强心脏手术中基于机器学习的死亡率预测:释放基于机器学习的风险评分的全部潜力。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezaf001
Hamrish Kumar Rajakumar
{"title":"Enhancing machine learning based mortality predictions in cardiac surgery: unlocking the full potential of ML-based risk scores.","authors":"Hamrish Kumar Rajakumar","doi":"10.1093/ejcts/ezaf001","DOIUrl":"10.1093/ejcts/ezaf001","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143002595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do socioeconomic factors impair uptake of neoadjuvant therapy for patients with locoregional oesophageal cancer? 社会经济因素是否影响局部食管癌患者接受新辅助治疗?
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezae462
Rajika Jindani, Jorge Humberto Rodriguez-Quintero, Isaac Loh, Grace Ha, Justin Olivera, Justin Rosario, Roger Zhu, Mohamed K Kamel, Marc Vimolratana, Neel P Chudgar, Brendon M Stiles

Objectives: The benefits of neoadjuvant therapy prior to surgery for patients with locally advanced oesophageal cancer have been well established by multiple trials. However, there may be socioeconomic barriers impacting equitable administration. We aim to identify whether disparities exist in the uptake of neoadjuvant therapy among patients with loco-regional oesophageal cancer.

Methods: We queried the National Cancer Database to identify patients with clinical stage II-III oesophageal cancer who underwent surgical resection (2006-2020). Logistic regression was performed to identify associations between sociodemographic factors and uptake of neoadjuvant therapy. In propensity score-matched groups, survival was evaluated using the Kaplan-Meier method.

Results: Among 19 748 clinical stage II-III patients, 85% (n = 16 781) received neoadjuvant therapy and 15% (n = 2967) underwent upfront surgery. Rates of neoadjuvant uptake increased over time. On multivariable analysis after adjusting by clinical stage, factors associated with lower rates of neoadjuvant therapy included older age (age ≥70, adjusted odds ratio 0.52; 95% confidence interval 0.47-0.57; P < 0.001), female sex (0.76; 0.69-0.85; P < 0.001), Black race (0.77; 0.63-0.94; P = 0.009), more comorbidities (0.76; 0.65-0.85; P < 0.001) and government rather than private insurance (0.84; 0.76-0.93; P < 0.001). In a propensity-matched cohort accounting for these variables, neoadjuvant treatment was associated with improved 5-year overall survival compared to upfront surgery (41.1% vs 35.4%, P < 0.001).

Conclusions: Several sociodemographic factors are associated with the delivery of neoadjuvant therapy in patients with oesophageal cancer, including age, sex, race, and insurance status. Interventions can be put into place to target vulnerable patients and ensure equitable delivery of care.

目的:局部晚期食管癌患者术前新辅助治疗的益处已经通过多项试验得到了很好的证实。然而,可能存在影响公平管理的社会经济障碍。我们的目的是确定在局部-区域食管癌患者中是否存在新辅助治疗的差异。方法:我们查询了国家癌症数据库,确定了2006-2020年接受手术切除的临床II-III期食管癌患者。采用Logistic回归来确定社会人口学因素与新辅助治疗之间的关系。在倾向评分匹配组中,使用Kaplan-Meier法评估生存率。结果:在19,748例临床II-III期患者中,85% (n = 16,781)接受了新辅助治疗,15% (n = 2,967)接受了术前手术。新辅助剂的接受率随着时间的推移而增加。在经临床分期调整后的多变量分析中,与新辅助治疗率较低相关的因素包括年龄较大(年龄≥70岁,调整优势比0.52;95%置信区间0.47-0.57;结论:一些社会人口学因素与食管癌患者的新辅助治疗有关,包括年龄、性别、种族和保险状况。可以针对弱势患者实施干预措施,并确保公平提供护理。
{"title":"Do socioeconomic factors impair uptake of neoadjuvant therapy for patients with locoregional oesophageal cancer?","authors":"Rajika Jindani, Jorge Humberto Rodriguez-Quintero, Isaac Loh, Grace Ha, Justin Olivera, Justin Rosario, Roger Zhu, Mohamed K Kamel, Marc Vimolratana, Neel P Chudgar, Brendon M Stiles","doi":"10.1093/ejcts/ezae462","DOIUrl":"10.1093/ejcts/ezae462","url":null,"abstract":"<p><strong>Objectives: </strong>The benefits of neoadjuvant therapy prior to surgery for patients with locally advanced oesophageal cancer have been well established by multiple trials. However, there may be socioeconomic barriers impacting equitable administration. We aim to identify whether disparities exist in the uptake of neoadjuvant therapy among patients with loco-regional oesophageal cancer.</p><p><strong>Methods: </strong>We queried the National Cancer Database to identify patients with clinical stage II-III oesophageal cancer who underwent surgical resection (2006-2020). Logistic regression was performed to identify associations between sociodemographic factors and uptake of neoadjuvant therapy. In propensity score-matched groups, survival was evaluated using the Kaplan-Meier method.</p><p><strong>Results: </strong>Among 19 748 clinical stage II-III patients, 85% (n = 16 781) received neoadjuvant therapy and 15% (n = 2967) underwent upfront surgery. Rates of neoadjuvant uptake increased over time. On multivariable analysis after adjusting by clinical stage, factors associated with lower rates of neoadjuvant therapy included older age (age ≥70, adjusted odds ratio 0.52; 95% confidence interval 0.47-0.57; P < 0.001), female sex (0.76; 0.69-0.85; P < 0.001), Black race (0.77; 0.63-0.94; P = 0.009), more comorbidities (0.76; 0.65-0.85; P < 0.001) and government rather than private insurance (0.84; 0.76-0.93; P < 0.001). In a propensity-matched cohort accounting for these variables, neoadjuvant treatment was associated with improved 5-year overall survival compared to upfront surgery (41.1% vs 35.4%, P < 0.001).</p><p><strong>Conclusions: </strong>Several sociodemographic factors are associated with the delivery of neoadjuvant therapy in patients with oesophageal cancer, including age, sex, race, and insurance status. Interventions can be put into place to target vulnerable patients and ensure equitable delivery of care.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142970211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Society of Thoracic Surgeons Presidential Address 2024. Adapting to change: embracing lifelong learning curves. 2024年欧洲胸外科学会主席演讲。适应变化:拥抱终身学习曲线。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezae446
József Furák
{"title":"European Society of Thoracic Surgeons Presidential Address 2024. Adapting to change: embracing lifelong learning curves.","authors":"József Furák","doi":"10.1093/ejcts/ezae446","DOIUrl":"https://doi.org/10.1093/ejcts/ezae446","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":"67 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posterior cricoid plate drill enlargement in idiopathic subglottic stenosis. 特发性声门下狭窄后环状板钻孔增大。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezae457
Beatrice Trabalza Marinucci, Cecilia Menna, Fabiana Messa, Giorgia Piccioni, Giacomo Argento, Matteo Tiracorrendo, Anna Maria Ciccone, Alessandra Siciliani, Giulio Maurizi, Antonio D'Andrilli, Claudio Andreetti, Erino Angelo Rendina, Mohsen Ibrahim

Objectives: Idiopathic subglottic stenosis (ISS) is an airway stricture between larynx and trachea, within 1 cm from the vocal cords. Resection-reconstruction present technical issues because of the need to resect the anterior portion of the cricoid cartilage, but not the posterior plate beyond which the recurrent laryngeal nerves access the vocal cords. The main surgical challenge consists of the minute airway calibre short below the cords, ensuing after the resection. We propose drill posterior cricoid plate moulding to obtain antero-posterior and lateral amplification of the laryngo-tracheal anastomosis.

Methods: This is a retrospective study of patients who underwent laryngo-tracheal resection with drill enlargement between January 2023 and June 2024. Laryngo-tracheal resection was performed according to Pearson's technique. At this point, airway calibre is gauged by endotracheal tubes of increasing size. To enlarge the air space, the inner surface of the posterior plate was moulded by drill. Breathing, complications, voice and swallowing function were recorded.

Results: Our study includes 23 consecutive patients with ISS. No mortality was described. Fifteen patients (65.2%) described voice alteration and 7 (30.4%) experienced transient swallowing impairment. The mean operative time was 94.56 (±28.72) min. All patients breathed well at discharge. Overall early success rate was excellent (no sequelae) in 7 (30.4%) patients, and good (grade A: voice/breathing changes not influencing the quality of life; grade B: abnormal voice and shortness of breath, not hindering normal activities) in 15 (65.2%). At the mean follow-up of 10.5 ± 5.5 months, definitive success was achieved.

Conclusions: This is the first study describing this technique. The results of our early experience with drill moulding of the posterior cricoid plate are promising. It is an innovative, simple, safe, and effective method for subglottic airway enlargement in ISS, resulting in low post-operative complications, and in good to excellent results.

目的:特发性声门下狭窄(ISS)是喉和气管之间的气道狭窄,距离声带1厘米以内。切除-重建存在技术问题,因为需要切除环状软骨的前部,但不切除喉返神经进入声带的后板。主要的手术挑战包括切除后短于声带以下的微小气道口径。我们建议钻孔后环状板成型,以获得喉-气管吻合的前后及外侧放大。方法:本研究是对2023年1月至2024年6月期间接受喉气管切除术并扩大钻孔的患者进行回顾性研究。根据Pearson进行喉气管切除术。此时,气道口径通过增大的气管内管测量。为了扩大空气空间,后板内表面采用钻孔成型。记录呼吸、并发症、声音和吞咽功能。结果:我们的研究包括23例连续的ISS患者。没有死亡率描述。15名患者(65.2%)描述了声音改变,7名患者(30.4%)经历了短暂的吞咽障碍。平均手术时间94.56(±28.72)min,出院时呼吸良好。7例(30.4%)患者的总体早期成功率为极好(无后遗症),良好(A级:声音/呼吸改变不影响生活质量;B级:声音异常、呼吸急促,未妨碍正常活动)15例(65.2%)。平均随访10.5±5.5个月,最终成功。结论:这是首次描述该技术的研究。我们对环状后板钻孔成型的早期经验是有希望的。它是一种新颖、简单、安全、有效的治疗ISS声门下气道扩张的方法,术后并发症少,效果良好。Irb:防。n。港。n. C. 139/ 2023年12月
{"title":"Posterior cricoid plate drill enlargement in idiopathic subglottic stenosis.","authors":"Beatrice Trabalza Marinucci, Cecilia Menna, Fabiana Messa, Giorgia Piccioni, Giacomo Argento, Matteo Tiracorrendo, Anna Maria Ciccone, Alessandra Siciliani, Giulio Maurizi, Antonio D'Andrilli, Claudio Andreetti, Erino Angelo Rendina, Mohsen Ibrahim","doi":"10.1093/ejcts/ezae457","DOIUrl":"10.1093/ejcts/ezae457","url":null,"abstract":"<p><strong>Objectives: </strong>Idiopathic subglottic stenosis (ISS) is an airway stricture between larynx and trachea, within 1 cm from the vocal cords. Resection-reconstruction present technical issues because of the need to resect the anterior portion of the cricoid cartilage, but not the posterior plate beyond which the recurrent laryngeal nerves access the vocal cords. The main surgical challenge consists of the minute airway calibre short below the cords, ensuing after the resection. We propose drill posterior cricoid plate moulding to obtain antero-posterior and lateral amplification of the laryngo-tracheal anastomosis.</p><p><strong>Methods: </strong>This is a retrospective study of patients who underwent laryngo-tracheal resection with drill enlargement between January 2023 and June 2024. Laryngo-tracheal resection was performed according to Pearson's technique. At this point, airway calibre is gauged by endotracheal tubes of increasing size. To enlarge the air space, the inner surface of the posterior plate was moulded by drill. Breathing, complications, voice and swallowing function were recorded.</p><p><strong>Results: </strong>Our study includes 23 consecutive patients with ISS. No mortality was described. Fifteen patients (65.2%) described voice alteration and 7 (30.4%) experienced transient swallowing impairment. The mean operative time was 94.56 (±28.72) min. All patients breathed well at discharge. Overall early success rate was excellent (no sequelae) in 7 (30.4%) patients, and good (grade A: voice/breathing changes not influencing the quality of life; grade B: abnormal voice and shortness of breath, not hindering normal activities) in 15 (65.2%). At the mean follow-up of 10.5 ± 5.5 months, definitive success was achieved.</p><p><strong>Conclusions: </strong>This is the first study describing this technique. The results of our early experience with drill moulding of the posterior cricoid plate are promising. It is an innovative, simple, safe, and effective method for subglottic airway enlargement in ISS, resulting in low post-operative complications, and in good to excellent results.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142846335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diminished spinal cord perfusion despite distal aortic perfusion: an acute translational large animal experiment with occluded segmental arteries. 远端主动脉灌注后脊髓灌注减少:一项节段性动脉闭塞的急性平移大动物实验。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezae460
Josephina Haunschild, Zara Dietze, Susann Ossmann, Konstantin Von Aspern, Jörg Naumann, Michael A Borger, Christian D Etz

Objectives: Neuroprotective measures have been established in open thoraco-abdominal aortic aneurysm repair to reduce the incidence of postoperative paraplegia. Distal aortic perfusion (DaP) is meant to increase blood flow to the abdominal organs and the spinal cord. Cerebrospinal fluid (CSF) drainage is part of peri- and postoperative clinical routine. We aimed to investigate the effect of both techniques on spinal cord perfusion in an acute large animal model with segmental artery occlusion.

Methods: Eight pigs underwent minimally invasive segmental artery coil embolization prior to establishment of cardiopulmonary bypass with DaP. After initiation of DaP, CSF pressure was increased 3-fold by infusion of blood plasma. Collateral network near-infrared spectroscopy was used as an additional real-time monitoring method for indirect perfusion monitoring. Microspheres were injected for post-mortem regional spinal cord blood flow analysis.

Results: DaP led to an increase in spinal cord perfusion limited to the very lower spinal cord (L3-S, up to 400% of baseline) and the corresponding paraspinous muscle area. The most vulnerable region between T8 and L2 was not reached by DaP (between 14% and 46% of baseline). After initiation of DaP, a 10% increase in oxygenation via collateral network near-infrared spectroscopy was observed for the low lumbar region. The increase in CSF pressure counteracted enhanced perfusion inflow leading to a decrease in net tissue perfusion.

Conclusions: DaP is effective in increasing blood flow to the distal spinal cord (effectively counteracting CSF pressure increase) and paraspinous muscles, despite occluded segmental arteries, resulting in hyperperfusion potentially leading to spinal cord oedema and delayed paraplegia postoperatively.

目的:建立开放性胸腹主动脉瘤修复术中的神经保护措施,降低术后截瘫的发生率。主动脉远端灌注(DaP)旨在增加流向腹部器官和脊髓的血流量。脑脊液(CSF)引流是围手术期和术后临床常规的一部分。我们的目的是研究这两种技术对急性节段性动脉闭塞大动物模型脊髓灌注的影响。方法:对8头猪行微创节段性动脉圈栓塞术,建立DaP体外循环。启动DaP后,经血浆输注后脑脊液压力升高3倍。侧支网络近红外光谱作为间接灌注监测的附加实时监测方法。注射微球用于死后局部脊髓血流分析。结果:DaP导致脊髓灌注增加,仅限于脊髓极下段(L3-S,高达基线的400%)和相应的棘旁肌区。在T8和L2之间的最脆弱区域,DaP未达到(基线的14%至46%之间)。在启动DaP后,通过cnNIRS观察到下腰椎区氧合增加10%。脑脊液压力的增加抵消了灌注流入的增强,导致净组织灌注减少。结论:尽管节段性动脉闭塞,但DaP可有效增加脊髓远端(有效抵消脑脊液压力升高)和棘旁肌肉的血流量,导致高灌注,可能导致脊髓水肿和术后迟发性截瘫。
{"title":"Diminished spinal cord perfusion despite distal aortic perfusion: an acute translational large animal experiment with occluded segmental arteries.","authors":"Josephina Haunschild, Zara Dietze, Susann Ossmann, Konstantin Von Aspern, Jörg Naumann, Michael A Borger, Christian D Etz","doi":"10.1093/ejcts/ezae460","DOIUrl":"10.1093/ejcts/ezae460","url":null,"abstract":"<p><strong>Objectives: </strong>Neuroprotective measures have been established in open thoraco-abdominal aortic aneurysm repair to reduce the incidence of postoperative paraplegia. Distal aortic perfusion (DaP) is meant to increase blood flow to the abdominal organs and the spinal cord. Cerebrospinal fluid (CSF) drainage is part of peri- and postoperative clinical routine. We aimed to investigate the effect of both techniques on spinal cord perfusion in an acute large animal model with segmental artery occlusion.</p><p><strong>Methods: </strong>Eight pigs underwent minimally invasive segmental artery coil embolization prior to establishment of cardiopulmonary bypass with DaP. After initiation of DaP, CSF pressure was increased 3-fold by infusion of blood plasma. Collateral network near-infrared spectroscopy was used as an additional real-time monitoring method for indirect perfusion monitoring. Microspheres were injected for post-mortem regional spinal cord blood flow analysis.</p><p><strong>Results: </strong>DaP led to an increase in spinal cord perfusion limited to the very lower spinal cord (L3-S, up to 400% of baseline) and the corresponding paraspinous muscle area. The most vulnerable region between T8 and L2 was not reached by DaP (between 14% and 46% of baseline). After initiation of DaP, a 10% increase in oxygenation via collateral network near-infrared spectroscopy was observed for the low lumbar region. The increase in CSF pressure counteracted enhanced perfusion inflow leading to a decrease in net tissue perfusion.</p><p><strong>Conclusions: </strong>DaP is effective in increasing blood flow to the distal spinal cord (effectively counteracting CSF pressure increase) and paraspinous muscles, despite occluded segmental arteries, resulting in hyperperfusion potentially leading to spinal cord oedema and delayed paraplegia postoperatively.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-implant transcatheter aortic prosthesis deformation: tricuspid versus bicuspid valve. 经导管主动脉假体植入后的变形:三尖瓣与二尖瓣。
IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-26 DOI: 10.1093/ejcts/ezae451
Marco Moscarelli, Aniket Venkatesh, Katelynne Berland, Breandan Yeats, Taylor Becker, Gregorio Zaccone, Vincenzo Pernice, Sabrina Milo, Adriana Zlahoda-Huzior, Dariusz Dudek, Francesca Trizzino, Giuseppe Speziale, Lakshmi Prasad Dasi, Khalil Fattouch

Objectives: We sought to assess whether post-implant transcatheter aortic valve prosthesis multidetector computed characteristics differ between patients with native tricuspid and bicuspid aortic valve stenosis, as well as the effect on valve performance and clinical implications.

Methods: We analysed 100 consecutive post-implant multidetector computed tomography scans to assess self-expandable prosthesis non-uniform expansion at 6 pre-specified valvular levels, and other specific parameters, including valvular and perivalvular thrombosis at 6 months follow-up. Echocardiographic prosthesis performance and clinical outcome were also evaluated.

Results: Mean eccentricity was significantly higher in the bicuspid group (0.43 (0.09) vs 0.37 (0.08), P = 0.005, bicuspid vs tricuspid); valvular and perivalvular thrombosis were also significantly more frequent in the bicuspid than in the tricuspid group (81% vs 36.9%, P = 0.031); there was no significant difference in terms of mean prosthetic gradient at follow-up between (7.31 (5.53 mmHg) vs 7.09 (3.05 mmHg), P = 0.825); EOAi (indexed effective orifice area) was also similar between bicuspid and tricuspid (1.08 (0.12 cm2) vs 1.03 (0.13 cm2), P = 0.101), with no significant changes compared to discharge. However, the bicuspid valve was associated with a significantly higher risk of adverse events (HR: 3.72, 95% CI: 1.07-13.4, P = 0.027).

Conclusions: Higher level of eccentricity, which indicates prosthesis deformation, is often detected in bicuspid valves. Although echocardiographic performance was not affected, this might have led to an increased incidence of thrombosis at valvular and perivalvular levels and worse outcomes.

目的:我们试图评估原生三尖瓣和双尖瓣主动脉瓣狭窄患者植入经导管主动脉瓣假体后多探测器计算机特征是否存在差异,以及对瓣膜性能和临床意义的影响:我们分析了 100 例连续的植入后多探测器计算机断层扫描,以评估自膨胀假体在 6 个预先指定的瓣膜水平上的非均匀膨胀,以及其他特定参数,包括随访 6 个月时的瓣膜和瓣周血栓形成。此外,还对超声心动图假体性能和临床结果进行了评估:结果:双尖瓣组的平均偏心率明显高于三尖瓣组(0.43 (0.09) vs 0.37 (0.08),p = 0.005,双尖瓣组 vs 三尖瓣组);双尖瓣组的瓣膜和瓣周血栓形成率也明显高于三尖瓣组(81% vs. 36.9%,p = 0.031)。031);随访时平均人工瓣膜梯度(7.31 (5.53 mmHg) vs 7.09 (3.05 mmHg),p = 0.825)之间无明显差异;EOAi在二尖瓣和三尖瓣之间也相似(1.08 (0.12 cm2) vs 1.03 (0.13 cm2),p = 0.101),与出院时相比无明显变化。然而,二尖瓣发生不良事件的风险明显更高(HR:3.72,95%CI:1.07-13.4,p = 0.027):结论:二尖瓣的偏心率较高,这表明假体变形。尽管超声心动图表现未受影响,但这可能会导致瓣膜和瓣周血栓形成的发生率增加,并使预后变差。
{"title":"Post-implant transcatheter aortic prosthesis deformation: tricuspid versus bicuspid valve.","authors":"Marco Moscarelli, Aniket Venkatesh, Katelynne Berland, Breandan Yeats, Taylor Becker, Gregorio Zaccone, Vincenzo Pernice, Sabrina Milo, Adriana Zlahoda-Huzior, Dariusz Dudek, Francesca Trizzino, Giuseppe Speziale, Lakshmi Prasad Dasi, Khalil Fattouch","doi":"10.1093/ejcts/ezae451","DOIUrl":"10.1093/ejcts/ezae451","url":null,"abstract":"<p><strong>Objectives: </strong>We sought to assess whether post-implant transcatheter aortic valve prosthesis multidetector computed characteristics differ between patients with native tricuspid and bicuspid aortic valve stenosis, as well as the effect on valve performance and clinical implications.</p><p><strong>Methods: </strong>We analysed 100 consecutive post-implant multidetector computed tomography scans to assess self-expandable prosthesis non-uniform expansion at 6 pre-specified valvular levels, and other specific parameters, including valvular and perivalvular thrombosis at 6 months follow-up. Echocardiographic prosthesis performance and clinical outcome were also evaluated.</p><p><strong>Results: </strong>Mean eccentricity was significantly higher in the bicuspid group (0.43 (0.09) vs 0.37 (0.08), P = 0.005, bicuspid vs tricuspid); valvular and perivalvular thrombosis were also significantly more frequent in the bicuspid than in the tricuspid group (81% vs 36.9%, P = 0.031); there was no significant difference in terms of mean prosthetic gradient at follow-up between (7.31 (5.53 mmHg) vs 7.09 (3.05 mmHg), P = 0.825); EOAi (indexed effective orifice area) was also similar between bicuspid and tricuspid (1.08 (0.12 cm2) vs 1.03 (0.13 cm2), P = 0.101), with no significant changes compared to discharge. However, the bicuspid valve was associated with a significantly higher risk of adverse events (HR: 3.72, 95% CI: 1.07-13.4, P = 0.027).</p><p><strong>Conclusions: </strong>Higher level of eccentricity, which indicates prosthesis deformation, is often detected in bicuspid valves. Although echocardiographic performance was not affected, this might have led to an increased incidence of thrombosis at valvular and perivalvular levels and worse outcomes.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142822007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Cardio-Thoracic Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1